Introduction {#s1}
============

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide \[[@R01]\]. Endoscopic resection of colorectal neoplastic epithelial lesions can prevent CRC \[[@R02], [@R03]\]. Endoscopic mucosal resection, performed using injection of physiological saline into the submucosa to a separate lesion from the muscularis propria (conventional endoscopic mucosal resection (C-EMR)), is widely used as a resection technique. In recent years, however, "underwater" EMR (U-EMR) has emerged as an alternative technique, in which the lumen is filled with water to "float" both the mucosa and submucosa \[[@R04]-[@R11]\]. Immersion of the lesion in water reduces its diameter, compared to air insufflation, which makes resection of large lesions easier than with C-EMR \[[@R08]\]. U-EMR is also reported as a useful salvage procedure for recurrent colorectal adenoma after piecemeal endoscopic resection \[[@R12]\], or for lesions involving the appendiceal orifice \[[@R13]\].

In Japan, endoscopic submucosal dissection (ESD) is widely performed for laterally spreading tumors \[[@R14]\], but its indication for colorectal ESD technique is limited to lesions ≥ 20 mm in diameter. Furthermore, because of its technical difficulty, not all lesions ≥ 20 mm can be resected using ESD and, therefore, piecemeal EMR is still widely performed for some neoplastic epithelial lesions ≥ 20 mm \[[@R14]\]. On the other hand, the frequency of cold polypectomy, which does not require an electrosurgical unit, is increasing, although use of this technique is generally limited to lesions \< 10 mm in diameter \[[@R15], [@R16]\]. Therefore, EMR is still one of the most frequently used techniques for the treatment of colorectal lesions in Japan. EMR, however, is usually performed under air or carbon deoxidate insufflation, with evidence for U-EMR being limited. As such, our aim in this study was to evaluate our initial experience with U-EMR in a Japanese setting.

Materials and Methods {#s2}
=====================

Study design {#s2a}
------------

This is a single-center, retrospective case series. We analyzed the clinical outcomes of consecutive patients who underwent U-EMR in our endoscopy center, from December 2015 to February 2017. Endoscopic resection of colorectal lesions, 10 to 19 mm in diameter, was performed using the U-EMR technique. All procedures were either performed or supervised by one staff endoscopist (TK), who has performed over 1,000 cases of C-EMR, but having no prior experience with U-EMR before the study period. Generally, at our center, cold polypectomy is used for lesions \< 10 mm. However, U-EMR was introduced for suspected cases of high-grade adenoma, even if the lesion was less \< 10 mm. Furthermore, although ESD is usually used for lesions with a diameter ≥ 20 mm that are suspected to be malignant, U-EMR was attempted for large diameter lesions in cases in which successful *en bloc* resection was expected. U-EMR was avoided when bowel preparation was poor.

Clinical outcomes were the *en bloc* resection rate, the complete resection rate, defined by a negative pathological margin for specimen successfully resected en-bloc, and post-procedural complications. Post-procedural bleeding was defined as hemorrhage after colonoscopy requiring endoscopic hemostasis. The *en bloc* resection rate and complications were evaluated for all lesions, whereas the complete resection rate was analyzed only for lesions with a neoplastic histology (low- or high-grade adenoma, mucosal or submucosal cancer, sessile serrated adenoma/polyp, and traditional serrated adenoma). Written informed consent was obtained from each patient before the procedure. The protocol for this retrospective analysis of our outcomes was approved by the institutional review board of Kyoto Second Red Cross Hospital.

Endoscopic procedure and data collection {#s2b}
----------------------------------------

For bowel preparation, magnesium citrate and/or sodium picosulfate hydrate were administered on the day prior to colonoscopy, with a 2 L polyethylene glycol preparation performed on the morning of the procedure. A standard high-definition videocolonoscope (Olympus, Tokyo, Japan), with a water jet system (i.e. CF-HQ290, PCF-H290), was used. Water (tap water or pure water) was prepared in the water jet system and injected until the lumen at the site of the lesion was filled ([Fig. 1](#F1){ref-type="fig"}). Local injection into the submucosa was not performed when the lesion could be adequately floated. A 10 or 33 mm snare (Captivator II, Boston Scientific, Natick, Massachusetts, USA) or a 13-mm rotatable snare (Boston Scientific) was used. Marking around a lesion before resection was not performed. The high-frequency ESG-100 generating device (Olympus, Tokyo, Japan) was used, with the high-frequency setting placed either on "pulse-cut slow" (20 W) or "forced coagulation 2" (15 W). After resection, retrieved lesions were fixed to a firm sponge for histological evaluation of the base of the lesion and its lateral margin. The lesions were soaked in formalin for \> 12 h and subsequently cut into formalin-fixed specimen at 2 mm intervals by a pathologist. Hematoxylin-eosin staining was performed for pathological diagnosis.

![Procedure for underwater endoscopic mucosal resection (U-EMR). (A, B) A sessile lesion about 30 mm located in the ascending colon. (C) The lumen at the site of the lesion was filled with water, using the water-jet system, and the lesion was floated in the lumen. (D) The lesion was snared, using a 33-mm snare, and the lesion was tightened-up. (E) The mucosal defect after U-EMR was usually smaller than after conventional EMR. (F) Resected specimen after successful *en bloc* resection.](gr-11-274-g001){#F1}

All data were collected in an endoscopic database (Solemio Endo, Olympus, Tokyo, Japan), with the location, size and morphology of the lesion inputted by the endoscopist soon after each procedure.

Results {#s3}
=======

Our analysis included 64 lesions, contributed by 38 patients, with a mean age of 68.6 years (range, 25 to 90 years; [Table 1](#T1){ref-type="table"}). Among the 64 lesions, 33 were right-sided lesions (oral side, from the splenic flexure), 24 left-sided and seven rectal. The relevant characteristics of the lesions were as follows: size, mean 16.2 mm (range, 6 to 40 mm); 42 lesions had a diameter \< 20 mm (66%), with the other 22 lesions (43%) having a diameter ≥ 20 mm; and 46 lesions (72%) were polypoid and 18 (28%) non-polypoid. Endoscopic ultrasound (EUS) imaging was performed before U-EMR in only three cases, in the early period of the study, to evaluate the status of the muscularis propria under a water-immersion condition. In all three cases that underwent EUS, we confirmed that only the mucosa and submucosa were floated in the water-immersion lumen, and, therefore, that the muscularis propria did not float. The final histological diagnoses were as follows: 31 low-grade adenomas, eight high-grade adenomas, 11 mucosal cancers, four submucosal cancers, and 10 classified as "others".

###### Patient and Lesion Characteristics

  ----------------------------------------- ------------------------
  Number of cases                           64 lesions in 38 cases
  Mean age, years (range)                   68.6 (25 - 90)
  Male sex, N (%)                           26 (68)
  Mean size of lesions, mm (range)          16.2 (6 - 40)
    \< 10 mm, N (%)                         8 (13)
    10 - 19 mm, N (%)                       34 (53)
    20 - 29 mm, N (%)                       15 (23)
    ≥ 30 mm, N (%)                          7 (11)
  Location                                  
    Cecum, N (%)                            9 (14)
    Ascending colon, N (%)                  12 (19)
    Transverse colon, N (%)                 12 (19)
    Descending colon, N (%)                 7 (11)
    Sigmoid colon, N (%)                    17 (27)
    Rectum, N (%)                           7 (11)
  Morphology                                
    0-Is, N (%)                             33 (52)
    0-Ip, N (%)                             10 (16)
    0-IIa, N (%)                            18 (28)
    0-IIa+Is, N (%)                         3 (5)
  Histology                                 
    Low-grade adenoma, N (%)                31 (48)
    High-grade adenoma, N (%)               8 (13)
    Mucosal cancer, N (%)                   11 (17)
    Submucosal cancer, N (%)                4 (6)
    Sessile serrated adenoma/polyp, N (%)   4 (6)
    Traditional serrated adenoma, N (%)     1 (2)
    Hyperplastic polyp, N (%)               3 (5)
    Inflammatory polyp, N (%)               2 (3)
  ----------------------------------------- ------------------------

*En bloc* resection was achieved in 52 (81%) lesions ([Table 2](#T2){ref-type="table"}). The *en bloc* resection rate was 95% for lesions \< 20 mm in diameter, compared to 55% for lesions with a diameter ≥ 20 mm. Complete resection was achieved in 32 of the 59 neoplastic epithelial lesions (54%), with a complete resection rate of 68% for lesions \< 20 mm, compared to 26% for lesions ≥ 20 mm. Negative vertical margins were achieved for all four submucosal cancers, with an adequate depth of tumor invasion evaluated ([Table 3](#T3){ref-type="table"}). Post-procedural bleeding was identified in three lesions (5%), with perforation identified in one lesion (2%); further surgical intervention was not required for treatment of these complications. Submucosal injection was required in only one case, with a 30 mm lesion located in the ascending colon that could not be adequately floated ([Fig. 2](#F2){ref-type="fig"}). This was the only case of perforation.

###### Study Outcomes

  --------------------------------- ---------------------------------------------
  *En bloc* resection rate          
    Overall, %                      81 (52/64 lesions)
    \< 10 mm, %                     100 (8/8)
    10 - 19 mm, %                   94 (32/34)
    20 - 29 mm, %                   53 (8/15)
    ≥ 30 mm, %                      57 (4/7)
  Complete resection rate‡          
    Overall, %                      54 (32 of 59 neoplastic epithelial lesions)
    \< 10 mm, %                     88 (7/8)
    10 - 19 mm, %                   63 (20/32)
    20 - 29 mm, %                   25 (3/12)
    ≥ 30 mm, %                      29 (2/7)
  Post procedural bleeding, N (%)   3 (5)
  Perforation, N (%)                1 (2)
  --------------------------------- ---------------------------------------------

‡Complete resection rate was defined by a negative pathological margin of resected specimen that was obtained by successful *en bloc* resection.

###### Cases of Submucosal Cancer in This Study

  -------------------------------- ------------------ ----------------- ---------------- -------
  Age (years)                      67                 71                90               85
  Sex                              F                  M                 M                M
  Location                         Ascending colon    Ascending colon   Sigmoid colon    Cecum
  Size (mm)                        40                 30                12               15
  Morphology                       0-IIa+Is (LST-G)   0-Is              0-IIa (LST-NG)   0-Is
  *En bloc* resection              No                 No                Yes              Yes
  Submucosal invasion depth (µm)   2,500              2,800             2,000            150
  Lateral margin                   N/A                N/A               \+               \-
  Base margin                      \-                 \-                \-               \-
  -------------------------------- ------------------ ----------------- ---------------- -------

LST-NG: laterally spreading tumor, non-granular type; LST-G: laterally spreading tumor, granular type; N/A: not applicable.

![A case of perforation. (A) A laterally spreading, granular type lesion about 30 mm located in the ascending colon. (B) Adequate floating of the lesion could not be achieved and, therefore, submucosal injection, using normal saline, was performed before snaring. (C) The lesion was snared, using a 33-mm snare, and the lesion was tightened-up. (D) *En bloc* resection was achieved but the muscularis propria was slightly injured at the center of the mucosal defect. (E) An obvious perforation was identified after gas insufflation in the lumen. (F) Endoscopic clipping was performed, and surgical intervention was not required.](gr-11-274-g002){#F2}

Discussion {#s4}
==========

In this study, U-EMR was used for the resection of colorectal lesions having an average diameter of 16.2 mm. An *en bloc* resection rate of 81% was achieved, with a complete resection rate of 58%. The *en bloc* resection rate for lesions \< 20 mm was 95%, compared to 55% for lesions ≥ 20 mm. Post-procedural bleeding and perforation, as complications, were identified in three (5%) and one (2%) lesion, respectively.

Previous studies evaluating U-EMR reported *en bloc* resection rates of 45 to 76% for tumors 18 to 30 mm in diameter \[[@R07]-[@R10]\]. Siau et al \[[@R10]\] reported *en bloc* resection rates of 82.9% for lesions 10 - 20 mm in diameter, 43.8% for a 20 - 30 mm diameter, 36.8% for a diameter of 30 - 40 mm, and 3.8% for a diameter \> 40 mm. By comparison, for C-EMR, using 0.13% hyaluronic acid solution, Yoshida et al \[[@R17]\] reported *en bloc* resection rates of 95.3% for lesions with a diameter of 5 - 10 mm and 85.1% for a diameter of lesions with a diameter of 10 - 20 mm. Saito et al \[[@R18]\] reported a C-EMR *en bloc* resection rate of 33% for lesions with a diameter ≥ 20 mm, compared to a rate of 84% for ESD. Similarly, in our study, the *en bloc* resection rate decreased when U-EMR was performed for lesions ≥ 20 mm in diameter.

With regard to complications, in their review of 4,000 cases of conventional polypectomy for polyps with an average diameter of 11 mm, Heldwein et al \[[@R19]\] reported a rate of post-procedural bleeding of 8.6% and a rate of perforation of 1.1%. For tumors with a diameter \> 20 mm, a meta-analysis revealed a post-procedural bleeding rate of 6.5% and a rate of perforation of 1.5% \[[@R20]\]. The post-procedural bleeding rate in our study was 5% and the rate of perforation was 2%. Therefore, the rate of complication after U-EMR was equivalent to that of C-EMR. With the rates of success and complications being comparable for U-EMR and C-EMR, the clinical advantages of U-EMR over C-EMR should be considered.

With U-EMR, a submucosal injection to lift the lesion is usually unnecessary and, therefore, there is no potential risk of dissemination of the tumor and post-EMR syndrome due to leakage of the solution out of the colonic wall. As a secondary benefit, U-EMR avoids the cost of the injection needle and solution. A third clinical advantage is that piecemeal resection is easier using U-EMR than C-EMR in cases when *en bloc* resection cannot be achieved. In their case review of colonic tumors ≥ 15 mm in diameter, many of which were resected using a piecemeal approach, Schenck et al reported a significantly lower rate of recurrence for U-EMR than C-EMR \[[@R11]\]. Fourth, U-EMR allows for easier clipping after resection than C-EMR. Although we did not specifically measure the mucosal defect after U-EMR, based on experience, the endoscopist considered the defect to be smaller for U-EMR than C-EMR.

As we mentioned above, U-EMR technique does not require submucosal injection, as per the original work by Binmoeller et al \[[@R04]\]. However, Siau et al reported that they used submucosal injection in approximately 30% of U-EMR cases \[[@R10]\]. In our case series, submucosal injection was required in one case in which adequate floating of the lesion could not be achieved. This was the only case of perforation we encountered. Ponugoti et al reported a case of perforation during U-EMR using a retroflexion technique in the ascending colon \[[@R21]\]. They suggested that the perforation resulted from stretching of the colonic wall by the retroflexed colonoscope, which prevented the lesion from being adequately floated. In our case of perforation, stretching of the colonic wall by the submucosal injection is likely to have been the cause. Therefore, care should be taken when performing U-EMR with submucosal injection.

U-EMR is usually performed for sessile lesions. However, 10 pedunculated polyps were included in our case series. Snaring of pedunculated polyps is usually easier to perform than for sessile lesions. However, snaring of pedunculated polyps is difficult when these are not aligned with gravity. Floating of the pedunculated polyps during U-EMR procedure makes snaring easier. Therefore, U-EMR would be useful not only for sessile lesions, but also for pedunculated lesions.

This study has several limitations that need to be acknowledged. First, this is a single-center, retrospective case series and, therefore, the possibility of selection bias cannot be excluded. Furthermore, important data, such as procedure time, was not obtained. Second, the study sample is small. Third, the long-term outcomes have not been evaluated. Even when we could not achieve *en bloc* resection, we removed all of lesions completely using a piecemeal resection technique. Careful follow-up is needed, especially for cases with piecemeal resection.

Despite these limitations, our data supports the clinical feasibility of U-EMR for the treatment of colorectal lesions. Although lesions ≥ 20 mm could be resected *en bloc* using the U-EMR technique, the *en bloc* resection rate was greater for lesions \< 20 mm than for lesions ≥ 20 mm.
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